Autonomic nervous system (ANS) disorders are common in multiple sclerosis (MS). Previous studies showed differences in insulin resistance (IR) and lipoprotein levels in MS subjects compared to controls. Lipolysis caused by increased sympathetic activity could be one of the possible linking mechanisms leading to dyslipidemia in MS. Our study aimed to evaluate ANS activity in the context of glucose and lipid metabolism in people with MS. We prospectively measured short-term heart rate variability (HRV), fasting lipoprotein concentrations, and calculated IR indices based on plasma glucose and insulin levels during oral glucose tolerance test (oGTT) in 32 patients with MS and 29 healthy controls matched for age, sex and body mass index in our study. There was no significant difference in HRV parameters and lipoprotein levels between MS and controls. A significant positive correlation was found between low/high-frequency power ratio (LF/HF) and triglycerides (r=0.413, p=0.021) in MS subjects but not in controls. A significantly lower whole-body insulin sensitivity index (ISIMat) was found in patients with MS compared to the control group (7.3±3.7 vs. 9.8±5.6, p=0.041). No significant correlations were found between LF/HF and IR parameters. In MS subjects, the positive correlation of LF/HF with triglycerides could reflect the effects of sympathetic activity on lipolysis. Positive correlations of sympathetic activity with increased lipoprotein levels could rather reflect processes associated with immune system activation/inflammation, than processes involved in glucose homeostasis maintenance.

1st Department of Neurology Faculty of Medicine Comenius University Slovakia

See more in PubMed

ADAMEC I, HABEK M. Autonomic dysfunction in multiple sclerosis. Clin Neurol Neurosurg. 2013;115(Suppl 1):S73–S78. https://doi:10.1016/j.clineuro.2013.09.026 . PubMed DOI

ANDERSON EA, HOFFMAN RP, BALON TW, SINKEY CA, MARK AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246–2252. https://doi:10.1172/JCI115260 . PubMed DOI PMC

BARTNESS TJ, LIU Y, SHRESTA YB, RYU V. Neural innervation of white adipose tissue and the control of lipolysis. Front Neuroendocrinol. 2014;35:473–493. https://doi:10.1016/j.yfrne.2014.04.001 . PubMed DOI PMC

BARTNESS TJ, SHRESTHA YB, VAUGHAN CH, SCHWARTZ GJ, SONG CK. Sensory and sympathetic nervous system control of white adipose tissue lipolysis. Mol Cell Endocrinol. 2010;318:34–43. https://doi:10.1016/j.mce.2009.08.031 . PubMed DOI PMC

BLACKBURN P, LEMIEUX I, LAMARCHE B. Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women. Diabetes Care. 2008;31:170–172. https://doi:10.2337/dc07-0272 . PubMed DOI

CARNETHON MR, JACOBS DR, Jr, SIDNEY S, LIU K. Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. Diabetes Care. 2003;26:3035–3041. https://doi:10.2337/diacare.26.11.3035 . PubMed DOI

CEDERHOLM J, WIBELL L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract. 1990;10:167–175. https://doi:10.1016/0168-8227(90)90040-z . PubMed DOI

FAHMI RM, El EBEARY M, ALRASHEED AM, ELKHATIB THM. Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients. Mult Scler Relat Disord. 2020;44:102336. https://doi:10.1016/j.msard.2020.102336 . PubMed DOI

FINDLING O, HAUER L, PEZAWAS T, ROMMER PS, STRUHAL W, SELLNER J. Cardiac autonomic dysfunction in multiple sclerosis: a systematic review of current knowledge and impact of immunotherapies. J Clin Med. 9:2020. https://doi:10.3390/jcm9020335 . PubMed DOI PMC

GEERLING JJ, BOON MR, KOOIJMAN S, PARLEVLIET ET, HAVEKES LM, ROMIJN JA, MEURUS IM, RENSEN PC. Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies. J Lipid Res. 2014;55:180–189. https://doi:10.1194/jlr.R045013 . PubMed DOI PMC

GIBBSONS CH. Basics of autonomic nervous system function. Handb Clin Neurol. 2019;160:407–18. https://doi:10.1016/B978-0-444-64032-1.00027-8 . PubMed DOI

GIUBILEI F, ANTONINI G, Di LEGGE S, SORMANI MP, PANTANO P, ANTONINI R, SEPE-MONTI M, CARAMIA F, POZZILLI C. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand. 2002;106:109–112. https://doi:10.1034/j.1600-0404.2002.01334.x . PubMed DOI

KANJWAL K, KARABIN B, KANJWAL Y, GRUBB BP. Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis. Int J Med Sci. 2010;7:62–67. https://doi:10.7150/ijms.7.62 . PubMed DOI PMC

KEREKES G, NURMOHAMED MT, GONZÁLES-GAY MA, SERES I, PARAGH G, KARDOS Z, BARÁTH Z, TAMÁSI L, SOLTÉSZ P, SZEKANECZ Z. Rheumatoid arthritis and metabolic syndrome. Nat Rev Rheumatol. 2014;10:691–696. https://doi:10.1038/nrrheum.2014.121 . PubMed DOI

MAHOVIC D, LAKUSIC N. Progressive impairment of automonic control of heart rate in patients with multiple sclerosis. Arch Med Res. 2007;38:322–325. https://doi:10.1016/j.arcmed.2006.11.009 . PubMed DOI

MATSUDA M, De FRONZO RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470. https://doi:10.2337/diacare.22.9.1462 . PubMed DOI

MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. https://doi:10.1007/BF00280883 . PubMed DOI

MIGLIS MG, MUPPIDI S. Autonomic dysfunction in multiple sclerosis and other updates on recent autonomic research. Clin Auton Res. 2018;28:391–393. https://doi:10.1007/s10286-018-0548-5 . PubMed DOI

NOORI H, GHEINI MR, REZAEIMANESH N, SAEEDI R, REZAEI ALIBADI H, SAHRAIAN MA, NASER MOGHADASI A. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients. Mult Scler Relat Disord. 2019;36:101415. https://doi:10.1016/j.msard.2019.101415 . PubMed DOI

PENESOVA A, VLCEK M, IMRICH R, VERNEROVA L, MARKO A, MESKOVA M, GRUNNEROVA L, TURCANI P, JEZOVA D, KOLLAR B. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis. Metab Brain Dis. 2015;30:895–901. https://doi:10.1007/s11011-015-9665-1 . PubMed DOI

POLMAN CH, REINGOLD SC, BANWELL B, CLANET M, COHEN JA, FILIPPI M, FUJIHARA K, HAVRDOVA E, HUTCHINSON M, KAPPOS L, LUBLIN FD, MONTALBAN X, O’CONNOR P, SANBERG-WOLLHEIM M, THOMPSON AJ, WAUBANT E, WEINSHENKER B, WOLINSKY JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302. https://doi:10.1002/ana.22366 . PubMed DOI PMC

RACOSTA JM, KIMPINSKI K. Autonomic dysfunction, immune regulation, and multiple sclerosis. Clin Auton Res. 2016;26:23–31. https://doi:10.1007/s10286-015-0325-7 . PubMed DOI

RADIKOVA Z, PENESOVA A, VLCEK M, HAVRANOVA A, SIVAKOVA M, SIARNIK P, ZITNANOVA I, IMRICH R, KOLLAR B, TURCANI P. LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity. Endocr Regul. 2018;52:139–45. https://doi:10.2478/enr-2018-0017 . PubMed DOI

RUIZ-ARGÜELLES A, MÉNDEZ-HUERTA MA, LOZANO CD, RUIZ-ARGÜELLES GJ. Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease. Mult Scler Relat Disord. 2018;25:316–321. https://doi:10.1016/j.msard.2018.08.014 . PubMed DOI

SEOANE-COLLAZO P, FERNØ P, GONZALES F, DIÉGUEZ C, LEIS R, NOGUEIRAS R, LÓPEZ M. Hypothalamic-autonomic control of energy homeostasis. Endocrine. 2015;50:276–291. https://doi:10.1007/s12020-015-0658-y . PubMed DOI

SICRAS-MAINAR A, EUÍZ-BEATO E, NAVARRO-ARTIEDA R, MAURINO J. Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain. BMC Neurol. 2017;17:134. https://doi:10.1186/s12883-017-0914-2 . PubMed DOI PMC

SZABÓ MZ, SZODORAY P, KISS E. Dyslipidemia in systemic lupus erythematosus. Immunol Res. 2017;65:543–550. https://doi:10.1007/s12026-016-8892-9 . PubMed DOI

THOMPSON AJ, BARANZINI SE, GEURTS J, HEMMER B, CICCARELLI O. Multiple sclerosis. Lancet. 2018;391:1622–1636. https://doi:10.1016/S0140-6736(18)30481-1 . PubMed DOI

VIDEIRA G, CASTRO P, VIEIRA B, FILIPE JP, SANTOS R, AZEVEDO E, SÁ MJ, ABREU P. Autonomic dysfunction in multiple sclerosis is better detected by heart rate variability and is not correlated with central autonomic network damage. J Neurol Sci. 2016;367:133–137. https://doi:10.1016/j.jns.2016.05.049 . PubMed DOI

VIEIRA B, COSTA A, VIDEIRA G, SÁ MJ, ABREU P. Prevalence of autonomic dysfunction in patients with multiple sclerosis. Acta Med Port. 2015;28:51–55. https://doi:10.20344/amp.5562 . PubMed DOI

VLCEK M, RADIKOVA Z, PENESOVA A, KVETNANSKY R, IMRICH R. Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton Neurosci. 2008;143:53–57. https://doi:10.1016/j.autneu.2008.08.001 . PubMed DOI

WEHRWEIN EA, ORER HS, BARMAN SM. Overview of the anatomy, physiology, and pharmacology of the autonomic nervous system. Compr Physiol. 2016;6:1239–1278. https://doi:10.1002/cphy.c150037 . PubMed DOI

WEINSTOCK-GUTTMAN B, ZIVADINOV R, MAHFOOZ N. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8:127. https://doi:10.1186/1742-2094-8-127 . PubMed DOI PMC

ZHORNITSKY S, McKAY KA, METZ LM, TEUNISSEN CE, RANGACHARI M. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53–65. https://doi:10.1016/j.msard.2015.10.005 . PubMed DOI